

Constellation Brands Dips; Centene Lower; Verint Possible Acquisition
Jul 2, 2025
The podcast dives into Constellation Brands facing challenges after a disappointing earnings report linked to weaker beer sales. Centene Corp. also struggles, pulling its 2025 guidance amid adverse insurance market trends, which could impact $1.8 billion in revenue. In a brighter vein, Verint Systems sees a stock boost as acquisition talks with Thoma Bravo heat up. The discussion unveils how these companies are maneuvering through a shifting market landscape while offering insights into healthcare innovations aimed at cost reduction.
AI Snips
Chapters
Transcript
Episode notes
Constellation Brands Market Shift
- Constellation Brands is facing weaker demand and higher costs, especially for beer due to a 25% aluminum tariff.
- The company is shifting marketing focus from Hispanic to non-Hispanic consumers amid inflation and job security concerns.
Centene's Insurance Market Challenges
- Centene Corp. pulled 2025 guidance due to insurance market trends threatening $1.8 billion in revenue.
- A "step up" in Medicaid costs is increasing key medical expenses, affecting industry forecasts.
Verint Potential Acquisition Buzz
- Verint Systems shares rose on buyout talks with private equity firm Thoma Bravo.
- There is no certainty in the deal, but the news lifted the company's stock price significantly.